 Home > Medical News > Latest Medical News > Microchip's "Cioroni Capsule" launches Phase III clinical trial for small cell lung cancer

Microchip's "Cioroni Capsule" launches Phase III clinical trial for small cell lung cancer

 Last Update: 2021-04-18
 Source: Internet
 Author: User

Tags

treatment

central drug system

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, the Insight database revealed that Microchip Bio-Sioroni Capsules has launched a Phase III clinical trial for the treatment of small cell lung cancer that has progressed or recurred after a 2-line system of chemotherapy.

Sioroni is a new chemical structure with global patent protection independently designed and developed by Microchip.

In the previous clinical trials of Sioroni, compared with historical control data, for SCLC patients who failed multi-line therapy, his single-agent therapy achieved very positive results.

At present, according to the Insight database, Sioroni has carried out 8 clinical trials, with indications covering ovarian cancer, liver cancer, breast cancer, lymphoma, and other neuroendocrine tumors.

Source: Insight database (http://db.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.